Navigation Links
Umbilical cord blood cell therapy in an animal model of Alzheimer's disease
Date:3/26/2008

New Rochelle, NY, March 26, 2008A novel strategy based on targeted immune suppression using human umbilical cord blood cells may improve the pathology and cognitive decline associated with Alzheimers disease, based on the results of a study in a mouse model of this currently untreatable neurodegenerative condition, as described in a groundbreaking report in Stem Cells and Development (www.liebertpub.com/scd), a peer-reviewed journal published by Mary Ann Liebert, Inc (www.liebertpub.com). The paper will be available free online (http://www.liebertonline.com/toc/scd/0/0).

Following a series of low-dose infusions of human umbilical cord blood cells into mice with Alzheimers-like disease, the amount of amyloid- and -amyloid plaqueshallmarks of Alzheimers pathology in the brainwas markedly reduced. Amyloid- induces an inflammatory response in the brain associated with the interaction of CD40 and CD40L, two pro-inflammatory molecules.

Human umbilical cord blood cell therapy was associated with suppression of CD40-CD40L activity, suggesting that this therapeutic approach modulates the activity of the immune system, offering the potential to target the pathogenic inflammatory response that may contribute to a variety of degenerative conditions, including Alzheimers disease.

Jun Tan, PhD, MD, and colleagues from USF (Tampa), Yale University (New Haven, CT), Cedars-Sinai Medical Center (Los Angeles, CA), Saneron CCEL Therapeutics (Tampa, FL), and Saitama Medical School (Japan), concluded that human umbilical cord blood cell-induced disruption of the CD40-CD40L interaction may alleviate the key pathologic changes in the brain associated with Alzheimers disease in a report entitled, Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer
'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

1

GOOD

Page: 1 2

Related biology news :

1. Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice
2. Diabetes makes it hard for blood vessels to relax
3. Weill Cornell team discovers how brains own tPA helps regulate blood flow to neurons
4. High blood pressure in older adults traced to genes effects in blood vessels
5. Eltrombopag effective for hepatitis C patients with low blood-platelet counts
6. MIT works toward engineered blood vessels
7. Blood pressure drug telmisartan shows powerful activity against stroke
8. Protein controls blood vessel formation, offers new drug target
9. Looking through the eyes of a mouse, scientists monitor circulating cells in its bloodstream
10. Study of malaria parasite in patient blood finds distinct physiological states
11. Blood clotting protein linked to rheumatoid arthritis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...r 1, 2009: OptiNose is pleased to announce the pub...dy investigating the efficacy and tolerability of ...topical treatment of chronic rhinosinusitis with n...f the International and European Rhinologic Societ... is a chronic disease that can significantly reduc...
(Date:12/1/2009)...eorgia Institute of Technology has been awarded a ...structures for energy harvesting and adaptive mate...ognitive processes of the modern warfighter. , ...abled Inorganic/Organic Nanostructures and Improve...mir Tsukruk and Kenneth Sandhage, professors in Ge...
(Date:12/1/2009)...rld first, a Monash University-led international r...ost the output of the next generation of solar cel...oration with colleagues from the universities of W... dye-sensitised solar cells with a three-fold incr... previously reported tandem dye-sensitised solar c...
Breaking Biology News(10 mins):New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4Innovation puts next-generation solar cells on the horizon 2Journal of Midwifery 26amp 3B Womens Health honors outstanding authors 54619 1Journal of Midwifery 26amp 3B Womens Health honors outstanding authors 54619 2Imagenetix Inc Announces Interview With Bloomberg Radio 13589 1Imagenetix Inc Announces Interview With Bloomberg Radio 13589 2Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 1Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 2Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 3Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 4
..., Ohio (April 21, 2008) The technique lizards use...rding to researchers at Ohio University. , A res...acked 18 different species of lizards as they walk...g styles impact their biomechanics. The study, fun...ed in the April 1 edition of the Journal of Experi...
...urg, Va. Researchers from the Virginia Bioinforma...lleagues have identified a key function of a large...nt role in the production of infectious disease by...ofessor Brett Tyler and members of his research gr...partment of Plant Pathology, Physiology and Weed S...
...E #1 FOR IMMEDIATE RELEASE , Gel-like material... Biomacromolecules , Researchers in Texas report...p speed the long-awaited arrival of insulin that c...njections. The study is scheduled for the April 14.... , In the report, Nicholas A. Peppas and colleag...
Other Biology News:Lizard hunting styles impact ability to walk, run 2American Chemical Society's Weekly PressPac -- April 16, 2008 2American Chemical Society's Weekly PressPac -- April 16, 2008 3American Chemical Society's Weekly PressPac -- April 16, 2008 4American Chemical Society's Weekly PressPac -- April 16, 2008 5American Chemical Society's Weekly PressPac -- April 16, 2008 6American Chemical Society's Weekly PressPac -- April 16, 2008 7American Chemical Society's Weekly PressPac -- April 16, 2008 8
(Date:12/1/2009)...NCLINE VILLAGE, Nev., Dec. 1 /PRNewswire-FirstCall...day announced revenue guidance for the fourth quar...illion, as compared with $69 million for the fourt... results was the first of two installment payments...fourth quarter 2008 results was a one-time $1.8 mi...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Reportlinke...is available in its catalogue: ,, Industrial E....reportlinker.com/p0164431/Industrial-Enzymes---A-...s market is an oligopoly with few strong players a...et activities. Keen competition and commoditizatio...
(Date:12/1/2009)...PLYMOUTH, Mass., Dec. 1 Harvest Te... today results from the company sponsored 60-patie...ical Center in Chennai, India using the company,s ...able Critical Limb Ischemia (CLI). Sri Ramachandra...-associated institution based in Chennai, India an...
(Date:12/1/2009)..., Former Majority Leader Richard Gephardt Bring...ine, Biotech Communities for "Best and Brightest ...N.J., Dec. 1 Several of...euticals, research, medicine and technology gather...the importance of medical innovation in New Jersey...
Breaking Biology Technology:PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5
...on Andy, Holder Completes First Year Inspiring Oth... Conditions, VALLEY FORGE, Pa., Jan. 17 In 2007...ppe(R), teamed up with "Iron Andy" Holder,as part ...campaign. Andy,set out to speak about living with ... resonated with dozens of individuals who were ins...
...ISON, N.J., Jan. 17 Wyeth Consumer Healthcare, a,...U.S. Food and Drug,Administration,s (FDA) decision...ugh and cold products in children under age two., ...emoval in October 2007,of over-the-counter infant ...help reduce dosing errors and overdoses in childre...
...or Advancement Towards Creating Patient-Specific a... For Therapeutic Use, LA JOLLA, Calif., Jan. 17 ...earch company, announced today it has become the,f...ment, a cloned human,embryo using somatic cell nuc...d, M.D., Ph.D., a co-author of the,publication and...
Other Biology Technology:Good Neighbor Pharmacy(R) Ironman Competitor Inspires Individuals with Diabetes to Live Without Limits 2Good Neighbor Pharmacy(R) Ironman Competitor Inspires Individuals with Diabetes to Live Without Limits 3Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age 2Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age 3Stemagen First to Create Cloned Human Embryos From Adult Cells 2Stemagen First to Create Cloned Human Embryos From Adult Cells 3
... Label IT siRNA Tracker Intracellular Localization...tly label and deliver siRNA, of your design, in an...o tracking experiments. Subcellular localization a... can be monitored following introduction of the la...
... Label IT siRNA Tracker Intracellular Localization...vides a straight forward approach to directly labe...nt yet non-destructive manner, for in vitro tracki...ional inhibition of target gene expression can be ...
...s kit allows for quick and reproducible immunoprec...e system is more reproducible than regular IPs, wh...otein A/G agarose without disrupting the agarose b... Catch and Release is reversible, and elution of t...
... Yeast Oligo Microarray Kit (V2), 2 x 11K will ena...ression of many thousands of yeast genes and ident...esses. Each microarray contains sequences represen... S288C strain of Saccharomyces cerevisiae, sourced...
Biology Products: